52329-04-1

Basic information

• Product Name: 5-Benzyloxy-2-Methoxybenzoesaeure-Methylester
• Synonyms: 5-Benzyloxy-2-Methoxybenzoesaeure-Methylester;Methyl 5-(benzyloxy)-2-methoxybenzoate
• CAS NO: 52329-04-1
• Molecular Formula: C₁₆H₁₆O₄
• Molecular Weight: 272.29584
• Mol File: 52329-04-1.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 411.0±30.0 °C(Predicted)
• Appearance: /
• Density: 1.153±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 5-Benzyloxy-2-Methoxybenzoesaeure-Methylester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Benzyloxy-2-Methoxybenzoesaeure-Methylester(52329-04-1)
• EPA Substance Registry System: 5-Benzyloxy-2-Methoxybenzoesaeure-Methylester(52329-04-1)

Safety Data

• Hazardous Substances Data: 52329-04-1(Hazardous Substances Data)

Upstream product

• 2150-46-1 Methyl 2,5-dihydroxybenzoate 
• 100-39-0 benzyl bromide 
• 61227-22-3 methyl 2-hydroxy-5-(phenylmethoxy)benzoate 
• 74-88-4 methyl iodide 
• 84923-68-2 5-(benzyloxy)-2-methoxybenzoic acid 
• 77-78-1 dimethyl sulfate 
• 16094-44-3 5-(benzyloxy)-2-hydroxybenzoic acid 

Downstream Products

• 52329-09-6 β-(5-Benzyloxy-2-methoxyphenyl)ethylamin 
• 52329-06-3 5-(benzyloxy)-2-methoxybenzaldehyde 
• 52329-08-5 5-Benzyloxy-2-methoxy-ω-nitrostyrol 
• 81860-99-3 N-tert-Butoxycarbonyl-cis-3-(3-cyanmethyl-4-methoxyphenoxy)prolin-methylester 
• 81860-99-3 N-tert-Butoxycarbonyl-trans-3-(3-cyanmethyl-4-methoxyphenoxy)prolin-methylester 
• 81860-97-1 cis-3-(3-Cyanmethyl-4-methoxyphenoxy)prolin 
• 81860-97-1 trans-3-(3-Cyanmethyl-4-methoxyphenoxy)prolin 
• 81860-96-0 3-(3-Cyanmethyl-4-methoxyphenoxy)-1-pyrrolin-2-carbonsaeure-methylester 
• 81860-94-8 (3-Brommethyl-4-methoxyphenyl)acetat 
• 87633-45-2 5-Hydroxy-2-methoxybenzylalkohol 
• 81860-95-9 5-Hydroxy-2-methoxybenzylcyanid 
• 87513-63-1 5-Hydroxy-2-methoxybenzoesaeure-methylester 
• 84923-68-2 5-(benzyloxy)-2-methoxybenzoic acid 

Relevant articles and documents

POLYCYCLIC AMIDES AS UBE2K MODULATORS FOR TREATING CANCER

Provided are compounds of Formula (I) and pharmaceutically acceptable salts and compositions thereof, which are useful for treating conditions associated with modulation of UBE2K.

Biaryl-propionic acid derivatives and their use as pharmaceuticals

The present invention relates to compounds of the formula I, wherein X, R, R1, R2, D, E1, E2, E3, E4, G1, G2, G3 and G4 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cath

Biaryl-Propionic Acid Derivatives and their Use as Pharmaceuticals

The present invention relates to compounds of the formula I, wherein X, R, R1, R2, D, E1, E2, E3, E4, G1, G2, G3 and G4 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cath